Millennium Case Analysis

1) Millennium was different from most other biotech firms that usually became dependent on large pharmaceutical firms because they did not have the resources to take their products to market or have a broad technology platform. Millennium sought to build varied technological capabilities i.e. a broad technology platform.

One of the key focuses of building technological capabilities was making the drug production process more efficient. This involved the use of advance technology like robotics & automation. Thus Millennium sought to build a technology platform and that was one of the capabilities that helped it become more successful in the 1990s.

This capability allowed them to focus on finding the most promising DNA and patenting it. Specifically it involved patenting the gene sequence, the specific protein produced by that gene & the engineered drug that was produced from the gene. Thus Millennium used its technological expertise to find out the most promising gene related ...